OTCQB:HDSLF - Post Discussion
Post by
Stockydoc on Apr 26, 2022 5:35pm
Q1 results looking good for $HS
Recently added this one to my watchlist and think there's tons of potential for growth here. Q1 financial results were great with $3.26M in lifetime revenues from fully executed deals. Total ARR under contract is also $4.45M. $HS.c is anticipating a strong Q2 and Q3 as the market is currently performing closer to its traditional cycle for the first time in two years. Contracts are lined up so we should see some more updates from the company soon. Current price of $0.61 is quite undervalued imo - great to see the company line up additional contracts. https://ca.finance.yahoo.com/news/healthspace-q1-sales-performance-3-113000102.html
Be the first to comment on this post